| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 30 | 2025 | 1536 | 2.980 |
Why?
|
| Genome-Wide Association Study | 23 | 2024 | 1837 | 2.870 |
Why?
|
| Polymorphism, Single Nucleotide | 31 | 2023 | 2855 | 2.840 |
Why?
|
| Melanoma | 9 | 2025 | 919 | 1.940 |
Why?
|
| Selection, Genetic | 6 | 2024 | 156 | 1.940 |
Why?
|
| Genetic Predisposition to Disease | 27 | 2023 | 3403 | 1.900 |
Why?
|
| Genome, Human | 15 | 2020 | 1331 | 1.660 |
Why?
|
| Skin Neoplasms | 7 | 2024 | 899 | 1.620 |
Why?
|
| Gene Expression Profiling | 14 | 2026 | 1831 | 1.520 |
Why?
|
| Mutation, Missense | 13 | 2024 | 929 | 1.490 |
Why?
|
| Prostatic Neoplasms | 11 | 2017 | 1415 | 1.450 |
Why?
|
| Codon, Nonsense | 3 | 2022 | 141 | 1.400 |
Why?
|
| Gene Expression Regulation, Neoplastic | 11 | 2025 | 1989 | 1.170 |
Why?
|
| Neoplasms | 7 | 2020 | 2965 | 1.040 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 676 | 1.030 |
Why?
|
| Genes, Neoplasm | 2 | 2019 | 80 | 0.940 |
Why?
|
| Gene Frequency | 6 | 2022 | 750 | 0.870 |
Why?
|
| Biomarkers, Tumor | 10 | 2025 | 1616 | 0.860 |
Why?
|
| Quantitative Trait Loci | 4 | 2022 | 307 | 0.740 |
Why?
|
| X Chromosome | 1 | 2023 | 331 | 0.730 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2023 | 327 | 0.720 |
Why?
|
| Computational Biology | 6 | 2015 | 871 | 0.690 |
Why?
|
| Scleroderma, Systemic | 2 | 2019 | 129 | 0.680 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 202 | 0.670 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2026 | 403 | 0.670 |
Why?
|
| Biological Evolution | 5 | 2015 | 229 | 0.630 |
Why?
|
| Humans | 79 | 2026 | 131136 | 0.610 |
Why?
|
| Mutation | 8 | 2024 | 6174 | 0.600 |
Why?
|
| Genetic Variation | 6 | 2020 | 1559 | 0.590 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 372 | 0.590 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2020 | 1008 | 0.510 |
Why?
|
| Models, Statistical | 3 | 2019 | 492 | 0.510 |
Why?
|
| RNA Splicing | 3 | 2014 | 235 | 0.480 |
Why?
|
| Blood | 1 | 2015 | 100 | 0.460 |
Why?
|
| Gene Expression | 2 | 2018 | 1495 | 0.450 |
Why?
|
| Genomics | 2 | 2014 | 1620 | 0.450 |
Why?
|
| Exons | 4 | 2014 | 769 | 0.450 |
Why?
|
| Male | 53 | 2026 | 64926 | 0.440 |
Why?
|
| Alleles | 5 | 2020 | 1709 | 0.440 |
Why?
|
| Genes, p53 | 2 | 2005 | 213 | 0.430 |
Why?
|
| Crossing Over, Genetic | 4 | 2001 | 53 | 0.430 |
Why?
|
| Carcinogenesis | 1 | 2017 | 356 | 0.420 |
Why?
|
| Logistic Models | 7 | 2022 | 1831 | 0.410 |
Why?
|
| Introns | 1 | 2014 | 288 | 0.390 |
Why?
|
| MicroRNAs | 3 | 2025 | 893 | 0.380 |
Why?
|
| Algorithms | 5 | 2016 | 1681 | 0.370 |
Why?
|
| Environmental Exposure | 1 | 2015 | 288 | 0.370 |
Why?
|
| Chromosomes, Human, Pair 15 | 4 | 2018 | 144 | 0.370 |
Why?
|
| Meiosis | 7 | 2001 | 112 | 0.370 |
Why?
|
| Recombination, Genetic | 4 | 2001 | 426 | 0.350 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2024 | 757 | 0.350 |
Why?
|
| Cryptorchidism | 4 | 2012 | 38 | 0.340 |
Why?
|
| CpG Islands | 4 | 2023 | 337 | 0.340 |
Why?
|
| Genotype | 14 | 2016 | 2656 | 0.340 |
Why?
|
| Case-Control Studies | 15 | 2024 | 3434 | 0.340 |
Why?
|
| Receptors, Nicotinic | 5 | 2012 | 132 | 0.340 |
Why?
|
| Lung | 4 | 2023 | 1564 | 0.340 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 656 | 0.330 |
Why?
|
| Oncogenes | 2 | 2022 | 164 | 0.330 |
Why?
|
| Neoplasm Staging | 6 | 2025 | 1322 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 5 | 3 | 2019 | 109 | 0.320 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2644 | 0.310 |
Why?
|
| Genes, Essential | 1 | 2009 | 43 | 0.310 |
Why?
|
| Genetics, Population | 3 | 2017 | 185 | 0.300 |
Why?
|
| Disease | 1 | 2010 | 126 | 0.300 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 73 | 0.300 |
Why?
|
| Membrane Proteins | 3 | 2019 | 1615 | 0.290 |
Why?
|
| DNA Methylation | 3 | 2024 | 1083 | 0.290 |
Why?
|
| Female | 35 | 2026 | 70829 | 0.280 |
Why?
|
| Chromosomes | 3 | 2000 | 118 | 0.270 |
Why?
|
| Carcinoma, Small Cell | 1 | 2007 | 39 | 0.270 |
Why?
|
| Organ Specificity | 2 | 2019 | 399 | 0.260 |
Why?
|
| Smoking | 8 | 2024 | 925 | 0.260 |
Why?
|
| Risk Factors | 17 | 2026 | 10929 | 0.250 |
Why?
|
| Adenocarcinoma | 6 | 2020 | 995 | 0.250 |
Why?
|
| Telomerase | 3 | 2019 | 157 | 0.240 |
Why?
|
| Homozygote | 4 | 2001 | 547 | 0.240 |
Why?
|
| Gene Expression Regulation | 3 | 2026 | 2355 | 0.230 |
Why?
|
| Middle Aged | 23 | 2026 | 28709 | 0.230 |
Why?
|
| Survival Analysis | 2 | 2019 | 1522 | 0.220 |
Why?
|
| Disease Progression | 3 | 2026 | 2204 | 0.220 |
Why?
|
| Point Mutation | 1 | 2006 | 339 | 0.220 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2977 | 0.220 |
Why?
|
| Prognosis | 11 | 2025 | 4937 | 0.210 |
Why?
|
| Receptors, G-Protein-Coupled | 3 | 2010 | 298 | 0.210 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2003 | 14 | 0.210 |
Why?
|
| Nucleic Acids | 1 | 2023 | 26 | 0.200 |
Why?
|
| Heterozygote | 4 | 2020 | 728 | 0.190 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 274 | 0.190 |
Why?
|
| Odds Ratio | 3 | 2022 | 1235 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 420 | 0.190 |
Why?
|
| Homeodomain Proteins | 2 | 2002 | 568 | 0.190 |
Why?
|
| Receptors, Androgen | 3 | 2016 | 417 | 0.190 |
Why?
|
| Nucleotides | 1 | 2022 | 90 | 0.180 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 1959 | 0.180 |
Why?
|
| Chromosome Mapping | 5 | 2012 | 1069 | 0.170 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2020 | 100 | 0.170 |
Why?
|
| Conserved Sequence | 1 | 2022 | 280 | 0.170 |
Why?
|
| Nigella sativa | 1 | 2020 | 1 | 0.170 |
Why?
|
| Trigonella | 1 | 2020 | 2 | 0.170 |
Why?
|
| Receptors, Cell Surface | 2 | 2002 | 432 | 0.170 |
Why?
|
| Proteins | 3 | 2018 | 1026 | 0.170 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2020 | 22 | 0.170 |
Why?
|
| Silent Mutation | 1 | 2020 | 3 | 0.170 |
Why?
|
| Chromosome Inversion | 2 | 1991 | 73 | 0.160 |
Why?
|
| Open Reading Frames | 2 | 2014 | 200 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 600 | 0.160 |
Why?
|
| Aged | 17 | 2025 | 21148 | 0.160 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 30 | 0.160 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 195 | 0.160 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 836 | 0.150 |
Why?
|
| Promoter Regions, Genetic | 1 | 2023 | 1217 | 0.150 |
Why?
|
| Phylogeny | 2 | 2018 | 707 | 0.150 |
Why?
|
| Mammals | 1 | 2000 | 259 | 0.150 |
Why?
|
| Principal Component Analysis | 2 | 2017 | 153 | 0.150 |
Why?
|
| Simuliidae | 1 | 2018 | 4 | 0.150 |
Why?
|
| Mucins | 1 | 2019 | 69 | 0.150 |
Why?
|
| Polytene Chromosomes | 1 | 2018 | 3 | 0.150 |
Why?
|
| Karyotype | 1 | 2018 | 29 | 0.140 |
Why?
|
| Transcriptome | 1 | 2025 | 1155 | 0.140 |
Why?
|
| Mutation Rate | 1 | 2018 | 68 | 0.140 |
Why?
|
| Risk | 1 | 2020 | 739 | 0.140 |
Why?
|
| Liver | 1 | 2026 | 1793 | 0.140 |
Why?
|
| Multivariate Analysis | 1 | 2022 | 1403 | 0.140 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 160 | 0.140 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 16 | 0.130 |
Why?
|
| Leukocytes | 1 | 2018 | 211 | 0.130 |
Why?
|
| Autoimmunity | 1 | 2018 | 181 | 0.130 |
Why?
|
| Linear Models | 1 | 2019 | 694 | 0.130 |
Why?
|
| Linkage Disequilibrium | 3 | 2012 | 319 | 0.130 |
Why?
|
| Adult | 10 | 2026 | 31539 | 0.130 |
Why?
|
| Testis | 3 | 2012 | 413 | 0.130 |
Why?
|
| Karyotyping | 6 | 2000 | 314 | 0.120 |
Why?
|
| Finasteride | 1 | 2016 | 16 | 0.120 |
Why?
|
| Mice | 12 | 2012 | 18457 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2014 | 684 | 0.120 |
Why?
|
| Cell Cycle Proteins | 2 | 2012 | 704 | 0.120 |
Why?
|
| Phenotype | 7 | 2018 | 4507 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 440 | 0.110 |
Why?
|
| Models, Genetic | 4 | 2008 | 750 | 0.110 |
Why?
|
| Prostatectomy | 1 | 2016 | 313 | 0.110 |
Why?
|
| Small Cell Lung Carcinoma | 2 | 2012 | 32 | 0.110 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2022 | 832 | 0.110 |
Why?
|
| Animals | 17 | 2022 | 34307 | 0.110 |
Why?
|
| Inflammation | 2 | 2012 | 1487 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 266 | 0.110 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 650 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2007 | 314 | 0.100 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2012 | 5 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 1993 | 182 | 0.090 |
Why?
|
| Life Style | 1 | 2015 | 444 | 0.090 |
Why?
|
| Decision Support Techniques | 1 | 2015 | 297 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2012 | 139 | 0.090 |
Why?
|
| Precision Medicine | 1 | 2015 | 374 | 0.090 |
Why?
|
| Cocarcinogenesis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Robotic Surgical Procedures | 1 | 2016 | 233 | 0.090 |
Why?
|
| Animal Feed | 2 | 2022 | 76 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 173 | 0.090 |
Why?
|
| Chickens | 2 | 2022 | 286 | 0.090 |
Why?
|
| Cluster Analysis | 1 | 2012 | 418 | 0.080 |
Why?
|
| Ligaments | 1 | 2010 | 20 | 0.080 |
Why?
|
| Software | 1 | 2016 | 751 | 0.080 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2023 | 219 | 0.080 |
Why?
|
| Laparoscopy | 1 | 2016 | 525 | 0.080 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2011 | 93 | 0.080 |
Why?
|
| Cardiovascular Diseases | 2 | 2020 | 2076 | 0.080 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2010 | 90 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2012 | 2361 | 0.080 |
Why?
|
| Genotyping Techniques | 2 | 2020 | 110 | 0.080 |
Why?
|
| beta Catenin | 1 | 2010 | 209 | 0.080 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 1125 | 0.070 |
Why?
|
| Receptors, Notch | 1 | 2010 | 204 | 0.070 |
Why?
|
| Genes, Overlapping | 1 | 2008 | 7 | 0.070 |
Why?
|
| Survival Rate | 2 | 2012 | 2141 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 57 | 0.070 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 707 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 164 | 0.070 |
Why?
|
| Europe | 2 | 2019 | 372 | 0.070 |
Why?
|
| Aged, 80 and over | 5 | 2024 | 6885 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1341 | 0.070 |
Why?
|
| Signal Transduction | 3 | 2012 | 4663 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2012 | 2289 | 0.060 |
Why?
|
| Diet | 3 | 2022 | 1118 | 0.060 |
Why?
|
| Spermatocytes | 1 | 1986 | 23 | 0.060 |
Why?
|
| Colorectal Neoplasms | 1 | 2012 | 633 | 0.060 |
Why?
|
| DNA, Recombinant | 1 | 2006 | 71 | 0.060 |
Why?
|
| PAX6 Transcription Factor | 2 | 2002 | 37 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 440 | 0.060 |
Why?
|
| Paired Box Transcription Factors | 2 | 2002 | 75 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1145 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2002 | 1236 | 0.060 |
Why?
|
| Polymorphism, Genetic | 2 | 2007 | 794 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2137 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2007 | 489 | 0.060 |
Why?
|
| Protein Isoforms | 2 | 2002 | 421 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 227 | 0.050 |
Why?
|
| Genetic Markers | 3 | 1993 | 605 | 0.050 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2004 | 19 | 0.050 |
Why?
|
| Eye Proteins | 2 | 2002 | 234 | 0.050 |
Why?
|
| Chromosome Aberrations | 2 | 2023 | 577 | 0.050 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 64 | 0.050 |
Why?
|
| Smokers | 1 | 2024 | 43 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2016 | 3103 | 0.050 |
Why?
|
| ROC Curve | 1 | 2025 | 614 | 0.050 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2003 | 39 | 0.050 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2003 | 52 | 0.050 |
Why?
|
| Haplotypes | 3 | 2011 | 543 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 3613 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1397 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2023 | 41 | 0.050 |
Why?
|
| Formaldehyde | 1 | 2023 | 40 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2007 | 1444 | 0.050 |
Why?
|
| Tissue Fixation | 1 | 2023 | 38 | 0.050 |
Why?
|
| Mentha piperita | 1 | 2022 | 12 | 0.050 |
Why?
|
| Relaxin | 1 | 2002 | 15 | 0.050 |
Why?
|
| Prebiotics | 1 | 2022 | 27 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 236 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2002 | 111 | 0.050 |
Why?
|
| Folic Acid | 1 | 2004 | 286 | 0.040 |
Why?
|
| DNA Primers | 1 | 2002 | 609 | 0.040 |
Why?
|
| Gene Deletion | 3 | 2012 | 774 | 0.040 |
Why?
|
| Retrospective Studies | 4 | 2024 | 17553 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2023 | 5115 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 785 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2002 | 410 | 0.040 |
Why?
|
| Repressor Proteins | 2 | 2002 | 777 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 1986 | 560 | 0.040 |
Why?
|
| Powders | 1 | 2020 | 26 | 0.040 |
Why?
|
| Tumor Burden | 2 | 2012 | 238 | 0.040 |
Why?
|
| Eye | 1 | 2002 | 228 | 0.040 |
Why?
|
| DNA | 2 | 2023 | 1444 | 0.040 |
Why?
|
| Jews | 1 | 2020 | 33 | 0.040 |
Why?
|
| Postmenopause | 1 | 2020 | 149 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 3674 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 722 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 496 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 635 | 0.040 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2004 | 530 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2025 | 1271 | 0.040 |
Why?
|
| Dietary Supplements | 1 | 2022 | 448 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 542 | 0.040 |
Why?
|
| Black Sea | 1 | 2018 | 1 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 53 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 748 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 550 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 698 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2003 | 1024 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 499 | 0.030 |
Why?
|
| Young Adult | 3 | 2018 | 10059 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2003 | 1227 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2020 | 638 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2022 | 984 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2568 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1710 | 0.030 |
Why?
|
| HapMap Project | 1 | 2016 | 13 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 374 | 0.030 |
Why?
|
| Transgenes | 2 | 2010 | 323 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2016 | 275 | 0.030 |
Why?
|
| Pathology, Molecular | 1 | 2015 | 63 | 0.030 |
Why?
|
| Age Distribution | 1 | 2016 | 429 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2015 | 286 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2016 | 306 | 0.030 |
Why?
|
| Biomarkers | 1 | 2023 | 3385 | 0.030 |
Why?
|
| Chromosome Banding | 2 | 1991 | 136 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2016 | 705 | 0.030 |
Why?
|
| Probability | 1 | 2013 | 310 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2013 | 320 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2013 | 436 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 4751 | 0.020 |
Why?
|
| Texas | 2 | 2012 | 3605 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2016 | 498 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2016 | 1631 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1993 | 773 | 0.020 |
Why?
|
| Urinary Tract Infections | 1 | 2016 | 327 | 0.020 |
Why?
|
| Sperm Count | 1 | 2012 | 92 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 22 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2012 | 129 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 34 | 0.020 |
Why?
|
| Patient Safety | 1 | 2016 | 443 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2002 | 366 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 631 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 434 | 0.020 |
Why?
|
| Muscle Development | 1 | 2010 | 68 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2002 | 722 | 0.020 |
Why?
|
| Adolescent | 3 | 2018 | 20849 | 0.020 |
Why?
|
| Quality Improvement | 1 | 2016 | 701 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 934 | 0.020 |
Why?
|
| Actins | 1 | 2012 | 317 | 0.020 |
Why?
|
| Genes | 1 | 2010 | 308 | 0.020 |
Why?
|
| Age Factors | 1 | 2016 | 2869 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 1990 | 171 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 1488 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2010 | 238 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 803 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1862 | 0.020 |
Why?
|
| Infertility, Male | 1 | 2012 | 295 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 2465 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 664 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2010 | 808 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2002 | 2563 | 0.020 |
Why?
|
| Cysteine Endopeptidases | 1 | 2008 | 110 | 0.020 |
Why?
|
| Heart Failure | 1 | 2020 | 2305 | 0.020 |
Why?
|
| Genetic Linkage | 1 | 2008 | 472 | 0.020 |
Why?
|
| 11-Hydroxycorticosteroids | 1 | 1986 | 1 | 0.020 |
Why?
|
| Testosterone | 1 | 2012 | 602 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2010 | 1001 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 297 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1390 | 0.010 |
Why?
|
| Aneuploidy | 1 | 1986 | 141 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2012 | 989 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8578 | 0.010 |
Why?
|
| Registries | 1 | 2012 | 1593 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 2783 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 5262 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1945 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2002 | 120 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13273 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2004 | 248 | 0.010 |
Why?
|
| Luciferases | 1 | 2002 | 127 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2002 | 260 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 15007 | 0.010 |
Why?
|
| Glycine | 1 | 2002 | 165 | 0.010 |
Why?
|
| Plasmids | 1 | 2002 | 455 | 0.010 |
Why?
|
| Contig Mapping | 1 | 2001 | 51 | 0.010 |
Why?
|
| Pigmentation | 1 | 2001 | 35 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2008 | 1094 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 414 | 0.010 |
Why?
|
| Transfection | 1 | 2002 | 960 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 1018 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2001 | 624 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 12891 | 0.010 |
Why?
|
| Infertility | 1 | 2001 | 79 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 567 | 0.010 |
Why?
|
| Spermatogenesis | 1 | 2001 | 171 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2001 | 755 | 0.010 |
Why?
|
| Peptides | 1 | 2002 | 835 | 0.010 |
Why?
|
| Protein Binding | 1 | 2002 | 1710 | 0.010 |
Why?
|
| Child | 1 | 2018 | 26174 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2001 | 4678 | 0.010 |
Why?
|
| Siberia | 1 | 1988 | 5 | 0.000 |
Why?
|
| Animals, Wild | 1 | 1988 | 30 | 0.000 |
Why?
|